Aquila Investment Management’s Guardant Health GH Stock Holding History

Aquila Investment Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-15,000	Closed	-$445K	–	87
2023 Q3	$445K	Hold	15,000	–	–	0.41%	75
2023 Q2	$537K	Hold	15,000	–	–	0.44%	80
2023 Q1	$352K	Sell	15,000 -15,000	-50%	-$428K	0.29%	84
2022 Q4	$816K	Buy	30,000 +12,000	+67%	+$549K	0.63%	73
2022 Q3	$969K	Hold	18,000	–	–	0.72%	63
2022 Q2	$726K	Buy	18,000 +8,000	+80%	+$396K	0.52%	77
2022 Q1	$662K	Hold	10,000	–	–	0.38%	77
2021 Q4	$1M	Buy	+10,000	New	+$1.03M	0.48%	80

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Aquila Investment Management's GH Position: Q4 2023 in Review

Aquila Investment Management sold out of Guardant Health (GH) in Q4 2023, closing a stake of 15,000 shares — an estimated $445K sold.

Aquila Investment Management first reported a position in GH in Q4 2021 and held it in 8 quarters. The position peaked at $1M in Q4 2021. 294 funds tracked by Wall St. Rank hold GH as of Q4 2023.

Aquila Investment Management reported no remaining Guardant Health position as of Q4 2023 after selling out during the quarter.
Aquila Investment Management sold 15,000 Guardant Health shares in Q4 2023, an estimated $445K.
Aquila Investment Management first reported a position in Guardant Health in Q4 2021 and held it in 8 quarters.
Aquila Investment Management's Guardant Health position peaked at $1M in Q4 2021.
294 funds tracked by Wall St. Rank held Guardant Health as of Q4 2023.

Based on Aquila Investment Management's 13F filing for Q4 2023, filed 29 Jan 2024.